糖化血红蛋白 (HbA1c) 检测的全球市场，预测到 2028 年

Global Hemoglobin A1C Testing Market, Forecast to 2028

出版日期: 2023年10月20日 | 出版商:

Frost & Sullivan | 英文 78 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

透过资料驱动的见解和创新分析为您的血红蛋白 A1c ( 主导) 测试决策提供支持

由于技术进步和床边检测 (POCT) 的日益普及，预计全球 HbA1c 检测市场将显着成长。即时血糖监测和传统的 HbA1c 测试相结合，透过提供最佳的治疗选择和更好的结果来彻底改变患者照护。这种整合简化了资料收集并提高了医疗保健环境中的业务效率。 POCT 选项也发挥重要作用，现场 HbA1c 检测可提供快速结果和快速反应时间，进一步提高患者满意度并节省宝贵的资产。

医疗设备製造商、医疗保健 IT 提供者和製药公司之间的合作将决定 HbA1c 测试市场的竞争形势。这些合作伙伴关係透过促进行业融合和整合解决方案的开发，使公司成为拥有尖端产品的市场领导。阶段利用这一趋势的公司将比竞争获得优势，并透过满足对综合糖尿病管理产品日益增长的需求来创造新的业务前景。

主要竞争
2021 年世界糖尿病要点
2021-2045 年糖尿病患者人数
成人患者数量排名前 10 名的国家/地区
成长指标
生长促进因子
成长抑制因素
预测假设
收益预测
收益预测分析
按地区分類的收益预测
按地区分類的收益预测分析
按环境分類的收益预测
按环境分類的收益预测分析
按最终用户分類的收益预测
按最终用户分類的收益预测分析
按技术分類的收益预测
按技术分類的收益预测分析
价格趋势与分析
玩家采取的主要定价策略
未来价格展望
全球 HbA1c 检测市场：值得注意的活动
全球 HbA1c 检测报销途径
竞争环境

值得关注的公司：实验室/POCT HbA1c 检测

特色公司：雅培实验室
特色公司：罗氏诊断
特色公司：西门子医疗
特色公司：贝克曼库尔特
特色公司：东曹株式会社
特色公司：Bio-Rad 实验室
特色公司：EKF 诊断
特色公司：Erba Diagnostics, Inc.
特色公司：Diazyme Laboratories
特色公司：PTS 诊断公司
特色公司：三一生物科技
竞争映射，由 HbA1c 提供的参数

成长机会宇宙

成长机会概览
成长机会 1：根据患者个体特征客製化 HbA1c 检测方法
成长机会 2：POCT 进步，实现准确、经济且使用者友好的 HbA1c 检测
成长机会 3：抓住不断成长的糖尿病照护市场的机会
成长机会 4：糖尿病 HbA1c 筛检以实现最佳护理和管理

下一步

简介目录

Product Code: K960-55

Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets.

Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products. Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the HbA1c Testing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of the Study
Segmentation by Setting
Segmentation by End Users
Segmentation by Technology

HbA1c Testing Overview

Key Competitors
Global Diabetes Highlights, 2021
Number of People with Diabetes, 2021-2045
Top 10 Countries or Territories for Number of Adults
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Region
Revenue Forecast Analysis by Region
Revenue Forecast By Setting
Revenue Forecast Analysis by Setting
Revenue Forecast by End Users
Revenue Forecast Analysis by End Users
Revenue Forecast by Technology
Revenue Forecast Analysis by Technology
Pricing Trends and Analysis
Key Pricing Strategies Adopted by Players
Future Aspect of Pricing
Global HbA1c Testing Market-Notable Activities
Global HbA1c Testing Reimbursement Pathways
Competitive Environment

Companies to Watch-Lab and POC HbA1c Testing

Companies to Watch-Abbott Laboratories
Companies to Watch-Roche Diagnostics
Companies to Watch-Siemens Healthineers
Companies to Watch-Beckman Coulter
Companies to Watch-Tosoh Corporation
Companies to Watch-Bio-Rad Laboratories
Companies to Watch-EKF Diagnostics
Companies to Watch-Erba Diagnostics, Inc.
Companies to Watch-Diazyme Laboratories
Companies to Watch-PTS Diagnostics
Companies to Watch-Trinity Biotech
Competitive Mapping by HbA1c Offering Parameters

Growth Opportunity Universe

Growth Opportunity Summary
Growth Opportunity 1-Tailoring HbA1c Testing Approaches to Individual Patient Characteristics
Growth Opportunity 2-Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing
Growth Opportunity 3-Capturing Opportunities in Growing Diabetes Care Markets
Growth Opportunity 4-Diabetes HbA1c Screening for Better Care and Management